VANCOUVER, BC — NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced that Mr. Mike Kelly, President &… Read More
Extends Labcorp’s leadership in genetic testing solutions for oncology and select rare diseases BURLINGTON, NC – Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the completion… Read More
SOUTH SAN FRANCISCO, CA – Abdera Therapeutics Inc., a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals for cancer, announced that Fierce… Read More
PGDx elio™ plasma focus Dx is the industry’s first and only kitted, pan-solid tumor liquid biopsy test that enables tumor mutation profiling – all from a simple blood draw BURLINGTON, NC… Read More
Dr. Stewart J. Tepper, MD has recently published a comprehensive paper in “Practical Neurology” on the latest developments in neuromodulation devices for the treatment of migraine. The paper, co-authored with… Read More
